ERBB2 and cancer: One of the cell receptors analyzed is the human epidermal growth factor receptor 2 (HER2), as its overexpression or amplification of its gene in breast tumors serves as a biomarker of aggressive cancer and a poor prognosis, which occurs in around 25% of cases [2,4,5].